TY - JOUR
T1 - Helicobacter pylori infection in subjects negative for high titer serum antibody
AU - Toyoshima, Osamu
AU - Nishizawa, Toshihiro
AU - Arita, Masahide
AU - Kataoka, Yosuke
AU - Sakitani, Kosuke
AU - Yoshida, Shuntaro
AU - Yamashita, Hiroharu
AU - Hata, Keisuke
AU - Watanabe, Hidenobu
AU - Suzuki, Hidekazu
N1 - Funding Information:
Toyoshima O received personal fees from Otsuka Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Co., Ltd. outside of the submitted work; Suzuki H received scholarship funds for the research from Astellas Pharma Inc., Astra-Zeneca K.K., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Zeria Pharmaceutical Co., Ltd. and received service honoraria from Astellas Pharma, Inc., Astra-Zeneca K.K., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Zeria Pharmaceutical Co., Ltd.
Publisher Copyright:
© 2018 The Author(s). Published by Baishideng Publishing Group Inc. All rights reserved.
PY - 2018/4/7
Y1 - 2018/4/7
N2 - AIM To investigate the clinicopathological features of the patients testing negative for high titer serum antiHelicobacter pylori (H. pylori) antibody. METHODS The antibody titers were measured using antigens derived from Japanese individuals. 13C-urea breath test-positive individuals were defined as having H. pylori infection. We investigated the demographic characteristics, laboratory data, endoscopic findings including Kyoto classifcation of gastritis, and histology in negative-high titer patients without H. pylori eradication therapy. Kyoto classification consisted of scores for gastric atrophy, intestinal metaplasia, enlarged folds, nodularity, and redness. RESULTS Of the 136 subjects enrolled, 23 (17%) had H. pylori infection. Kyoto classification had an excellent area under the receiver operating characteristics curve (0.886, 95% confdence interval: 0.803-0.968, P = 3.7 × 10-20) for predicting H. pylori infection with a cutoff value of 2. Further, Kyoto classification, H. pylori density, and neutrophil activity had high accuracies (89.7%, 96.3%, and 94.1%, respectively). Kyoto classifcation was independent of the demographic and laboratory parameters in multivariate analysis. CONCLUSION Endoscopic Kyoto classification of gastritis is a useful predictor of H. pylori infection in negative-high titer antibody patients.
AB - AIM To investigate the clinicopathological features of the patients testing negative for high titer serum antiHelicobacter pylori (H. pylori) antibody. METHODS The antibody titers were measured using antigens derived from Japanese individuals. 13C-urea breath test-positive individuals were defined as having H. pylori infection. We investigated the demographic characteristics, laboratory data, endoscopic findings including Kyoto classifcation of gastritis, and histology in negative-high titer patients without H. pylori eradication therapy. Kyoto classification consisted of scores for gastric atrophy, intestinal metaplasia, enlarged folds, nodularity, and redness. RESULTS Of the 136 subjects enrolled, 23 (17%) had H. pylori infection. Kyoto classification had an excellent area under the receiver operating characteristics curve (0.886, 95% confdence interval: 0.803-0.968, P = 3.7 × 10-20) for predicting H. pylori infection with a cutoff value of 2. Further, Kyoto classification, H. pylori density, and neutrophil activity had high accuracies (89.7%, 96.3%, and 94.1%, respectively). Kyoto classifcation was independent of the demographic and laboratory parameters in multivariate analysis. CONCLUSION Endoscopic Kyoto classification of gastritis is a useful predictor of H. pylori infection in negative-high titer antibody patients.
KW - Antibody
KW - Endoscopy
KW - Gastritis
KW - Helicobacter pylori
KW - Kyoto classifcation
UR - http://www.scopus.com/inward/record.url?scp=85045064692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045064692&partnerID=8YFLogxK
U2 - 10.3748/wjg.v24.i13.1419
DO - 10.3748/wjg.v24.i13.1419
M3 - Article
C2 - 29632423
AN - SCOPUS:85045064692
SN - 1007-9327
VL - 24
SP - 1419
EP - 1428
JO - World Journal of Gastroenterology
JF - World Journal of Gastroenterology
IS - 13
ER -